Word

Status

Pending

Status Code

733

Status Date

Friday, May 31, 2024

Serial Number

90522413

Mark Type

2

Filing Date

Wednesday, February 10, 2021

Published for Opposition

Tuesday, April 5, 2022

Trademark Owner History

CELLCARTA BIOSCIENCES INC. - 1st New Owner After Publication
Caprion Biosciences, Inc. - Owner At Publication

Classifications

9 Downloadable or recorded software for informatics, bioinformatics; Downloadable or recorded software for clinical trial data acquisition, validation, and analysis; Downloadable or recorded software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Downloadable or recorded software for managing information related to clinical trials; Specimen collection kits for scientific and medical research, comprised of specimen containers, vials, caps, and microscope slides; Specimen collection kits for clinical trial research, comprised of specimen containers, vials, caps, and microscope slides; plastic and glass tubes and vials for scientific and medical research sample collection and storage; laboratory equipment, namely, microscope slides; wipes and swabs for use in collecting samples for laboratory and clinical trial research; Testing sample collection equipment, namely, wipes, swabs, tubes, vials, and for use in experimental testing, not for medical purposes

39 Transportation and storage of goods, namely, clinical trial materials; transportation and storage of goods; transportation and storage of laboratory and clinical trial specimen collection kits; Shipping and delivery services, namely, pickup, transportation, and delivery of laboratory and clinical trial specimen collection kits; transportation of goods in ambient or temperature controlled conditions

16 Printed shipping labels; printed paper labels; printed paper labels for use on laboratory specimens; paper bar code labels; printed laboratory manuals the field of scientific and medical research; printed clinical trial procedures manuals; printed forms used in clinical trials; printed labels for use in organizing and tracking specimens for clinical trials; printed paper packaging materials for clinical trial sample collection kits

1 Assays for scientific and research purposes; assays for biomarker verification, validation, and application; assays for use in connection with mass spectrometry

45 Regulatory compliance consulting in the fields of pharmaceuticals and clinical diagnostics; Advice and consultancy on food, drug, and medical device regulatory matters; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical device

44 Genetic testing for medical purposes; Consulting services in the fields of diagnostic medical testing; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; immune monitoring, and genetic profiling for medical and diagnostic purposes

42 Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific research and development in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; immune monitoring, and genetic profiling for research and development purposes; scientific research and development in the field of mass cytometry, cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; providing laboratory testing services in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Software as a service (SAAS) services featuring software for informatics, bioinformatics; software as a service (SAAS) services featuring software for clinical trial data acquisition, validation, and analysis; Software as a service (SAAS) services featuring software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Software as a service (SAAS) services featuring software for cell cytometry; Software as a service (SAAS) services featuring software for managing information related to clinical trials

The mark consists of a rectangle above the diagonal arrangement of two squares and a rectangle.

Trademark Events

Feb 15, 2021

New Application Entered

May 14, 2021

New Application Office Supplied Data Entered

May 15, 2021

Notice Of Design Search Code E-Mailed

Aug 25, 2021

Assigned To Examiner

Aug 27, 2021

Non-Final Action Written

Aug 27, 2021

Non-Final Action E-Mailed

Aug 27, 2021

Notification Of Non-Final Action E-Mailed

Feb 25, 2022

Examiners Amendment -Written

Feb 25, 2022

Examiners Amendment E-Mailed

Feb 25, 2022

Notification Of Examiners Amendment E-Mailed

Feb 25, 2022

Examiner's Amendment Entered

Feb 25, 2022

Approved For Pub - Principal Register

Feb 28, 2022

Assigned To Lie

Mar 16, 2022

Notification Of Notice Of Publication E-Mailed

Apr 5, 2022

Published For Opposition

Apr 5, 2022

Official Gazette Publication Confirmation E-Mailed

May 31, 2022

Noa E-Mailed - Sou Required From Applicant

Nov 28, 2022

Sou Teas Extension Received

Nov 28, 2022

Sou Extension 1 Filed

Nov 28, 2022

Sou Extension 1 Granted

Nov 30, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 1, 2023

Automatic Update Of Assignment Of Ownership

Apr 26, 2023

Sou Teas Extension Received

Apr 26, 2023

Sou Extension 2 Filed

Apr 26, 2023

Sou Extension 2 Granted

Apr 28, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 28, 2023

Sou Teas Extension Received

Nov 28, 2023

Sou Extension 3 Filed

Nov 28, 2023

Sou Extension 3 Granted

Nov 29, 2023

Notice Of Approval Of Extension Request E-Mailed

May 31, 2024

Sou Teas Extension Received

May 31, 2024

Sou Extension 4 Filed

May 31, 2024

Sou Extension 4 Granted

Jun 13, 2024

Notice Of Approval Of Extension Request E-Mailed